Alfact Innovation Announces Positive Clinical Trial Results for Treatment of AIH- and HBV- Related Acute-on-Chronic Liver Diseases
11/4/2013 10:08:19 AM
PARIS--(BUSINESS WIRE)--Alfact Innovation, a young innovative biotechnology company focused on the discovery and the development of biopharmaceuticals to provide innovative therapies in hepatology and oncology disorders, announced positive results from Phase II clinical trial for treatment of AIH- and HBV- related acute-on-chronic liver diseases.
Help employers find you! Check out all the jobs and post your resume.
comments powered by